Sources: 12Gene Ontology See all sources |
Cellular components related to alopecia areata according to GeneDecks: (show all 16)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | MHC class II protein complex | GO:042613 | 10.1 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 2 | clathrin-coated endocytic vesicle membrane | GO:030669 | 10.1 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1, FCGR1B | | 3 | trans-Golgi network membrane | GO:032588 | 10.0 | HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRB1, HLA-DRB3 | | 4 | MHC class I protein complex | GO:042612 | 9.9 | HLA-C, HLA-B, HLA-A, MICA, ULBP3 | | 5 | transport vesicle membrane | GO:030658 | 9.9 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 6 | Golgi membrane | GO:000139 | 9.9 | NOTCH4, HLA-DRB3, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 7 | early endosome membrane | GO:031901 | 9.9 | FCGR1A, FCGR1B, HLA-A, HLA-B, HLA-C | | 8 | endocytic vesicle membrane | GO:030666 | 9.9 | NOS3, HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 9 | integral to lumenal side of endoplasmic reticulum membrane | GO:071556 | 9.7 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1, HLA-C | | 10 | ER to Golgi transport vesicle membrane | GO:012507 | 9.7 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1, HLA-C | | 11 | cell surface | GO:009986 | 8.7 | TGFB1, NOTCH4, TNFRSF1A, TNF, TPO, IL1R1 | | 12 | external side of plasma membrane | GO:009897 | 8.5 | HLA-DRB1, HLA-DRB3, TNF, CTLA4, CXCL9, ICOS | | 13 | integral to plasma membrane | GO:005887 | 8.1 | HLA-DQA2, HLA-DRB1, HLA-DRB3, TPO, TNF, TNFRSF1A | | 14 | plasma membrane | GO:005886 | 5.6 | TPO, HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 15 | extracellular region | GO:005576 | 5.4 | CCL11, CCL5, IGKC, IFNG, F8, ICOS | | 16 | extracellular space | GO:005615 | 3.9 | C5, CCL2, CCL11, CCL5, IFNG, F8 |
Biological processes related to alopecia areata according to GeneDecks: (show top 50)
(show all 70)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | immunoglobulin production involved in immunoglobulin mediated immune response | GO:002381 | 10.4 | HLA-DQB1, HLA-DRB1, HLA-DRB3 | | 2 | chronic inflammatory response to antigenic stimulus | GO:002439 | 10.3 | IL1RN, IL1B | | 3 | humoral immune response mediated by circulating immunoglobulin | GO:002455 | 10.3 | HLA-DRB3, HLA-DRB1, HLA-DQB1 | | 4 | detection of bacterium | GO:016045 | 10.2 | HLA-DRB3, HLA-DRB1, HLA-B, HLA-A | | 5 | T cell costimulation | GO:031295 | 10.2 | CTLA4, HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 6 | T cell receptor signaling pathway | GO:050852 | 10.1 | PTPN22, HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 7 | positive regulation of MHC class II biosynthetic process | GO:045348 | 10.1 | CIITA, IL10, IL4, IFNG | | 8 | response to amino acid stimulus | GO:043200 | 10.1 | CCL2, ICAM1, TNFRSF1A, NOS3 | | 9 | positive regulation of isotype switching to IgG isotypes | GO:048304 | 10.0 | IFNG, IL4, IL2, CD40 | | 10 | positive regulation vascular endothelial growth factor production | GO:010575 | 9.9 | C5, TGFB1, IL1B, IL1A | | 11 | positive regulation of tyrosine phosphorylation of Stat1 protein | GO:042511 | 9.9 | CD40, IFNG, TNFRSF1A | | 12 | regulation of immune response | GO:050776 | 9.8 | HLA-C, HLA-B, HLA-A, ICAM1, IGKC, IL4 | | 13 | cellular calcium ion homeostasis | GO:006874 | 9.8 | C5, TGFB1, CCL5, CCL11, CCL2, CD40 | | 14 | negative regulation of T cell proliferation | GO:042130 | 9.8 | IL10, HLA-DRB1, HLA-DRB3, TGFB1 | | 15 | positive regulation of T cell proliferation | GO:042102 | 9.7 | IFNG, CCL5, IL4, IL21, IL1B | | 16 | chemotaxis | GO:006935 | 9.7 | C5, CXCL9, CCL5, CCL11, CCL2, CCL27 | | 17 | positive regulation of calcidiol 1-monooxygenase activity | GO:060559 | 9.7 | TNF, IFNG, IL1B | | 18 | positive regulation of angiogenesis | GO:045766 | 9.7 | C5, NOS3, TNFRSF1A, CCL5, CCL11, IL1B | | 19 | cellular response to lipopolysaccharide | GO:071222 | 9.7 | ICAM1, IFNG, CCL2, IL8, IL10 | | 20 | interferon-gamma-mediated signaling pathway | GO:060333 | 9.7 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1, HLA-C | | 21 | cell surface receptor signaling pathway | GO:007166 | 9.5 | C5, EGFR, IFNG, CCL2, IL2RA, IL1R1 | | 22 | virus-host interaction | GO:019048 | 9.4 | PSIP1, TGFB1, TNFRSF1A, HLA-C, HLA-B, HLA-A | | 23 | positive regulation of chemokine biosynthetic process | GO:045080 | 9.4 | TNF, IFNG, IL4, IL1B | | 24 | positive regulation of fever generation | GO:031622 | 9.4 | TNF, CCL5, IL1B | | 25 | response to ethanol | GO:045471 | 9.3 | SOD1, NOS3, TNFRSF1A, ICAM1, CCL2, IL4 | | 26 | response to heat | GO:009408 | 9.2 | SOD1, PSIP1, NOS3, CCL2, IL1B, MICA | | 27 | aging | GO:007568 | 9.2 | TGFB1, NOS3, CCL5, CCL2, FAS, IL1B | | 28 | positive regulation of I-kappaB kinase/NF-kappaB cascade | GO:043123 | 9.2 | TNFRSF1A, TNF, TRAF1, FASLG, IL1B, IL1A | | 29 | protein kinase B signaling cascade | GO:043491 | 9.1 | TGFB1, TNF, CCL5, CCL2, IL1B | | 30 | response to activity | GO:014823 | 9.1 | IL10, CCL2, CCL5, TNF | | 31 | cellular response to organic cyclic compound | GO:071407 | 9.1 | TGFB1, TNF, CCL5, CCL2, IL1B | | 32 | lipopolysaccharide-mediated signaling pathway | GO:031663 | 8.9 | TGFB1, NOS3, TNF, CCL5, CCL2, IL1B | | 33 | positive regulation of cytokine secretion | GO:050715 | 8.9 | TNF, IL1A, IL10, INS, MIF | | 34 | induction of apoptosis | GO:006917 | 8.8 | C5, TGFB1, TNF, FAS, FASLG, CDKN2A | | 35 | response to glucocorticoid stimulus | GO:051384 | 8.8 | TNF, CCL5, CCL2, FAS, IL1RN, IL1B | | 36 | cytokine-mediated signaling pathway | GO:019221 | 8.8 | HLA-DQA2, HLA-DQA1, HLA-C, HLA-B, HLA-A, ICAM1 | | 37 | response to hypoxia | GO:001666 | 8.7 | TGFB1, NOS3, TNFRSF1A, TNF, CCL2, FAS | | 38 | positive regulation of mitosis | GO:045840 | 8.4 | TNF, IL1B, IL1A, INS | | 39 | positive regulation of nitric oxide biosynthetic process | GO:045429 | 8.4 | EGFR, TNF, ICAM1, IFNG, IL1B, INS | | 40 | positive regulation of NF-kappaB transcription factor activity | GO:051092 | 8.4 | TGFB1, TNF, TRAF1, ICAM1, IL1B, INS | | 41 | positive regulation of apoptotic process | GO:043065 | 8.2 | SOD1, NOS3, CTLA4, TNF, FAS, FASLG | | 42 | cell-cell signaling | GO:007267 | 8.1 | CXCL9, CCL5, CCL27, CCL4, FASLG, IL3 | | 43 | signal transduction | GO:007165 | 8.1 | CCL2, CCL11, HLA-DRB3, TRAF1, TNFSF13, TNFSF13B | | 44 | positive regulation of cell proliferation | GO:008284 | 8.0 | TGFB1, EGFR, TNFSF13B, TNFSF13, FASLG, IL3 | | 45 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | 7.9 | IFNG, AIRE, TNF, TNFRSF1A, TGFB1, PSIP1 | | 46 | response to drug | GO:042493 | 7.8 | NES, SOD1, TGFB1, NOS3, TNF, ICAM1 | | 47 | MAPK cascade | GO:000165 | 7.8 | TGFB1, EGFR, TNF, CCL5, CCL2, IL1B | | 48 | inflammatory response | GO:006954 | 7.6 | CCL5, TNF, TNFRSF1A, TGFB1, PRDX5, CXCL9 | | 49 | anti-apoptosis | GO:006916 | 7.6 | SOD1, NOS3, TNF, CCL2, FAS, IL2 | | 50 | immune response | GO:006955 | 7.0 | CXCL9, CTLA4, IL8, IL4, IL3, IL2RA |
Molecular functions related to alopecia areata according to GeneDecks: (show all 9)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | MHC class II receptor activity | GO:032395 | 10.1 | HLA-DRB3, HLA-DRB1, HLA-DQB1, HLA-DQA2, HLA-DQA1 | | 2 | CCR5 chemokine receptor binding | GO:031730 | 10.1 | CCL4, CCL5, NES | | 3 | MHC class I receptor activity | GO:032393 | 10.0 | HLA-C, HLA-B, HLA-A, ULBP3 | | 4 | interleukin-1 receptor binding | GO:005149 | 10.0 | IL1A, IL1B, IL1RN | | 5 | chemokine activity | GO:008009 | 9.5 | C5, CXCL9, CCL5, CCL11, CCL2, CCL27 | | 6 | receptor binding | GO:005102 | 9.3 | C5, PRDX5, TNFSF13B, TNFSF13, HLA-B, HLA-A | | 7 | tumor necrosis factor receptor binding | GO:005164 | 9.2 | TNFSF13B, TNFSF13, TNF, FASLG | | 8 | cytokine activity | GO:005125 | 7.4 | MIF, CXCL9, TNFSF13B, TNFSF13, TNF, IFNG | | 9 | protein binding | GO:005515 | 3.9 | TMPO, TNFSF13B, TNFRSF1A, TNF, TRAF1, HLA-DRB3 |
|